ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	6/11	120/7206	8.12214502549e-09
ko05167	Kaposi's sarcoma-associated herpesvirus infection	5/11	191/7206	5.03958035448e-06
ko04380	Osteoclast differentiation	4/11	134/7206	3.40994255901e-05
ko05166	HTLV-I infection	5/11	292/7206	3.98949484507e-05
ko05160	Hepatitis C	4/11	153/7206	5.74189862349e-05
ko04621	NOD-like receptor signaling pathway	4/11	157/7206	6.3527343759e-05
ko05164	Influenza A	4/11	167/7206	8.0874894895e-05
ko04210	Apoptosis	4/11	180/7206	0.000108324455145
ko05168	Herpes simplex infection	4/11	182/7206	0.000113083073459
ko04060	Cytokine-cytokine receptor interaction	4/11	191/7206	0.000136408712331
ko04620	Toll-like receptor signaling pathway	3/11	100/7206	0.000394680012805
ko05162	Measles	3/11	120/7206	0.000674083529173
ko05142	Chagas disease (American trypanosomiasis)	3/11	130/7206	0.000851536837465
ko04630	Jak-STAT signaling pathway	3/11	132/7206	0.000890266715221
ko04931	Insulin resistance	3/11	137/7206	0.00099197867694
ko04722	Neurotrophin signaling pathway	3/11	160/7206	0.00155486882049
ko04071	Sphingolipid signaling pathway	3/11	162/7206	0.00161157466076
ko04623	Cytosolic DNA-sensing pathway	2/11	41/7206	0.00168176716237
ko05161	Hepatitis B	3/11	173/7206	0.00194690083268
ko04217	Necroptosis	3/11	178/7206	0.00211277239823
ko04215	Apoptosis - multiple species	2/11	47/7206	0.00220600572258
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/11	182/7206	0.00225168580458
ko05152	Tuberculosis	3/11	187/7206	0.00243323667636
ko04062	Chemokine signaling pathway	3/11	201/7206	0.00298963655779
ko05014	Amyotrophic lateral sclerosis (ALS)	2/11	74/7206	0.00538934631348
ko01524	Platinum drug resistance	2/11	76/7206	0.00567718096712
ko05131	Shigellosis	2/11	82/7206	0.0065824246564
ko05220	Chronic myeloid leukemia	2/11	85/7206	0.0070582953544
ko05210	Colorectal cancer	2/11	86/7206	0.00722033241208
ko05203	Viral carcinogenesis	3/11	277/7206	0.00736900810099
ko04657	IL-17 signaling pathway	2/11	87/7206	0.00738406855637
ko04662	B cell receptor signaling pathway	2/11	88/7206	0.00754949920344
ko05222	Small cell lung cancer	2/11	89/7206	0.00771661977743
ko05323	Rheumatoid arthritis	2/11	89/7206	0.00771661977743
ko04920	Adipocytokine signaling pathway	2/11	89/7206	0.00771661977743
ko04064	NF-kappa B signaling pathway	2/11	96/7206	0.00893339902767
ko04650	Natural killer cell mediated cytotoxicity	2/11	97/7206	0.00911387522882
ko01521	EGFR tyrosine kinase inhibitor resistance	2/11	106/7206	0.0108118323453
ko05215	Prostate cancer	2/11	111/7206	0.0118116614664
ko04211	Longevity regulating pathway	2/11	123/7206	0.0143720699243
ko04660	T cell receptor signaling pathway	2/11	124/7206	0.0145955156759
ko01522	Endocrine resistance	2/11	124/7206	0.0145955156759
ko05145	Toxoplasmosis	2/11	126/7206	0.0150469939754
ko04933	AGE-RAGE signaling pathway in diabetic complications	2/11	135/7206	0.0171534825044
ko05418	Fluid shear stress and atherosclerosis	2/11	173/7206	0.027336649755
ko04150	mTOR signaling pathway	2/11	184/7206	0.030652237813
ko05200	Pathways in cancer	3/11	492/7206	0.0345603593115
ko05169	Epstein-Barr virus infection	2/11	206/7206	0.0377451036459